Why the study?
Does the albumin:creatinine ratio (ACR) from a first-morning void better predict renal events compared to other measures of urinary protein excretion in patients with type 2 diabetes and nephropathy?
Population
n=701 patients with type 2 diabetes and nephropathy (subset of the RENAAL trial)
Comparison
Measurement of urinary albumin:creatinine ratio… vs Other measures of urinary protein excretion…
Design
Cohort
Authors
Loading...
Supports first-morning ACR for renal risk prediction in type 2 diabetes; leaves open whether it should replace other measures in practice.
Does the albumin:creatinine ratio (ACR) from a first-morning void better predict renal events compared to other measures of urinary protein excretion in patients with type 2 diabetes and nephropathy?
Measurement of the albumin:creatinine ratio in a first-morning void is superior to 24-hour urine collections for predicting renal events in patients with type 2 diabetes and nephropathy.
Heerspink et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: